FDA Advocacy

Our Track Record:

The Network knows how the Food & Drug Administration (FDA) works better than most watchdog organizations operating on Capitol Hill – and we know how to bring your voices to them loud and clear when change is needed. Most recently, we successfully convinced the FDA to permanently remove medically unnecessary restrictions on the abortion pill, and were one of the first groups to testify during the FDA’s emergency authorization hearings for the COVID-19 vaccine.

What’s Next:

The NWHN will continue to press the FDA on: 

  • Mandating more diversity in clinical trials, so that all people regardless of their race, gender, fertility status, etc. can be included.  
  • Holding Big Pharma accountable to stringent safety and efficacy standards regarding sex drugs for women, which have a dubious history of both.  

Featured Resources

 

2024 Policy Agenda Social Media Graphic

The National Women’s Health Network’s 2024 Policy Agenda

Mifepristone Supreme Court Ruling 12.13.23 press release

The NWHN Urges the Supreme Court to Validate the Safety of Mifepristone as it Prepares to Hear Oral Arguments in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration 

OTC Birth Control Divider (1)

Ensuring Accessible Birth Control: Opill and the Path Forward

Opill Statement For Fb And Twitter

The NWHN Applauds the FDA’s Decision to Make a Birth Control Pill Available Over-the-Counter